Global Oncohematology Summit: CME and CPD-accredited

Can you name the methodologies for molecular monitoring of MRD in blood cancer patients?

And thanks to an exciting lineup of speakers, you will too after attending our virtual Global Oncohematology Summit, streaming live September 13 and 14.
I’ll be there!

Kicking off the summit with keynote speaker Dr. Elias Jabbour of MD Anderson Cancer Center, we’re bringing together experts specializing in a broad range of blood cancer malignancies for two days of educational presentations. Here are some of the insightful talks we’ve lined up for you:

 

CML and MPN
Prof. Susan Branford SA Pathology

Prof. Susan Branford
SA Pathology

Monitoring patients: Value of sensitive and standardized testing
 
Dr. Jean-Michel Cayuela Saint-Louis Hospital

Dr. Jean-Michel Cayuela
Saint-Louis Hospital

CML: Molecular measurable residual disease in practice.

 
Prof. Jean-Jacques Kiladjian Saint-Louis Hospital

Prof. Jean-Jacques Kiladjian
Saint-Louis Hospital

JAK2 V617F monitoring in MPN

 

AML
Dr. Giovanni Martinelli IRST IRCCS

Dr. Giovanni Martinelli
IRST IRCCS

New insights into AML testing and monitoring
 
Dr. Michael Heuser Hannover Medical School

Dr. Michael Heuser
Hannover Medical School

MRD testing in AML: Prime time in the clinic?

 

ALL
Dr. Nicola Gökbuget University Hospital Frankfurt

Dr. Nicola Gökbuget
University Hospital Frankfurt

Comprehensive evaluation for risk classification and treatment selection for Ph- ALL
 
Dr. Rathana Kim Saint-Louis Hospital

Dr. Rathana Kim
Saint-Louis Hospital

MRD as a tool to evaluate treatment response and predict relapse in Ph+ ALL

 

Multiple myeloma
Dr. Claudio Cerchione IRST IRCCS

Dr. Claudio Cerchione
IRST IRCCS

Importance of testing in multiple myeloma
 

 

Take the I Can pledge – a decision that improves patients’ lives – and join us for this must-attend virtual event.

 
Reserve your space

We can’t wait to see you there!

Kind regards,

Your QIAGEN Oncohematology team

PS – These eight insightful talks are just the start. We’ve organized a great lineup of additional speakers, including advocates who will speak about the patient perspective. Be sure to take a look at the full, two-day agenda.
Sample to Insight